Patents by Inventor Michael Hillier

Michael Hillier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250051312
    Abstract: The present invention relates to compositions of pibrentasvir, drug products thereof, and processes and intermediates for the preparation thereof.
    Type: Application
    Filed: February 28, 2024
    Publication date: February 13, 2025
    Applicant: ABBVIE INC.
    Inventors: Michael Hillier, Chirag Gheewala, Riley Hastings
  • Publication number: 20210171506
    Abstract: The present invention relates to compositions of pibrentasvir, drug products thereof, and processes and intermediates for the preparation thereof. This invention relates to the drug product, active drug substance, intermediates, and processes of pibrentasvir, a NS5A inhibitor that is useful in the treatment of hepatitis C.
    Type: Application
    Filed: August 29, 2019
    Publication date: June 10, 2021
    Applicant: AbbVie Inc.
    Inventors: Michael Hillier, Chirag Gheewala, Riley Hastings
  • Publication number: 20100292282
    Abstract: The present invention relates to a process for producing crystalline 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methyl-propyl]-5-fluorobenzonitrile, and novel salts, solvates, hydrates and polymorphs thereof.
    Type: Application
    Filed: October 20, 2008
    Publication date: November 18, 2010
    Inventors: Kevin R. Campos, Cheng-Yi Chen, Jennifer R. Foley, Michael Hillier, Wendy S. Jen, Amude M. Kassim, Artis Klapars, Andrey V. Peresypkin, Thorsten Rosner, Cecile G. Savarin, Matthew Tudge, Narayan Variankaval, Vicky Vydra, Dalian Zhao